These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 16948955)

  • 21. Minimally invasive image-guided therapies for hepatocellular carcinoma.
    Goldberg SN; Ahmed M
    J Clin Gastroenterol; 2002; 35(5 Suppl 2):S115-29. PubMed ID: 12394215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ablative techniques for hepatocellular carcinoma.
    Barnett CC; Curley SA
    Semin Oncol; 2001 Oct; 28(5):487-96. PubMed ID: 11685741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interventional radiology for hepatocellular carcinoma.
    Loffroy R
    Minerva Gastroenterol Dietol; 2011 Sep; 57(3):299-309. PubMed ID: 21769079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of Hepatocellular Carcinoma: Current Status and Future Directions.
    Au JS; Frenette CT
    Gut Liver; 2015 Jul; 9(4):437-48. PubMed ID: 26087860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multidisciplinary treatment of patients with hepatocellular carcinoma.
    Masaki T; Morishita A; Kurokohchi K; Kuriyama S
    Expert Rev Anticancer Ther; 2006 Oct; 6(10):1377-84. PubMed ID: 17069523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of focal liver ablation in the treatment of unresectable primary and secondary malignant liver tumors.
    Gannon CJ; Curley SA
    Semin Radiat Oncol; 2005 Oct; 15(4):265-72. PubMed ID: 16183480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Transarterial chemoembolization and conformal radiotherapy for hepatocellular carcinoma].
    Merle P; Mornex F
    Cancer Radiother; 2011 Feb; 15(1):69-71. PubMed ID: 21237690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase 2 study of stereotactic body radiotherapy and optional transarterial chemoembolization for solitary hepatocellular carcinoma not amenable to resection and radiofrequency ablation.
    Takeda A; Sanuki N; Tsurugai Y; Iwabuchi S; Matsunaga K; Ebinuma H; Imajo K; Aoki Y; Saito H; Kunieda E
    Cancer; 2016 Jul; 122(13):2041-9. PubMed ID: 27062278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Technology insight: Image-guided therapies for hepatocellular carcinoma--intra-arterial and ablative techniques.
    Hong K; Georgiades CS; Geschwind JF
    Nat Clin Pract Oncol; 2006 Jun; 3(6):315-24. PubMed ID: 16757969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Percutaneous ablation of hepatocellular carcinoma in older patients in clinical practice].
    Romero Gutiérrez M; Ruano Díaz L; Muñoz López D; Artaza Varasa T; González de Frutos C; Sánchez Ruano JJ; de la Cruz Pérez G; Gómez Rodríguez R
    Gastroenterol Hepatol; 2015 Feb; 38(2):54-61. PubMed ID: 25499846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Locally ablative therapies of hepatocellular carcinoma].
    Sturm JW; Keese MA; Bönninghoff RG; Wüstner M; Post S
    Onkologie; 2001 Sep; 24 Suppl 5():35-45. PubMed ID: 11600811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcome of regional and local ablative therapies for hepatocellular carcinoma: a collective review.
    Jansen MC; van Hillegersberg R; Chamuleau RA; van Delden OM; Gouma DJ; van Gulik TM
    Eur J Surg Oncol; 2005 May; 31(4):331-47. PubMed ID: 15837037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiofrequency ablation for hepatocellular carcinoma.
    Nishikawa H; Kimura T; Kita R; Osaki Y
    Int J Hyperthermia; 2013 Sep; 29(6):558-68. PubMed ID: 23937321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transarterial therapy: an evolving treatment modality of hepatocellular carcinoma.
    Jazieh KA; Arabi M; Khankan AA
    Saudi J Gastroenterol; 2014; 20(6):333-41. PubMed ID: 25434313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Goals and targets for personalized therapy for HCC.
    Couri T; Pillai A
    Hepatol Int; 2019 Mar; 13(2):125-137. PubMed ID: 30600478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical therapy of hepatocellular carcinoma.
    McCormack L; Petrowsky H; Clavien PA
    Eur J Gastroenterol Hepatol; 2005 May; 17(5):497-503. PubMed ID: 15827439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful treatment of large-size advanced hepatocellular carcinoma by transarterial chemoembolization followed by the combination therapy of percutaneous ethanol-lipiodol injection and radiofrequency ablation.
    Kurokohchi K; Hosomi N; Yoshitake A; Ohgi T; Ono M; Maeta T; Kiuchi T; Matsumoto I; Masaki T; Yoneyama H; Kohi F; Kuriyama S
    Oncol Rep; 2006 Nov; 16(5):1067-70. PubMed ID: 17016594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonsurgical treatment of hepatocellular carcinoma.
    Llovet JM; Sala M; Bruix J
    Liver Transpl; 2000 Nov; 6(6 Suppl 2):S11-5. PubMed ID: 11084079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of choice for unresectable small liver cancer: percutaneous ethanol injection therapy or transarterial chemoembolization therapy.
    Horiguchi Y; Sekoguchi B; Imai H; Suzuki T; Kubo H; Itoh H; Itoh M
    Cancer Chemother Pharmacol; 1994; 33 Suppl():S111-4. PubMed ID: 8137468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Iodized Oil Transarterial Chemoembolization and Radiofrequency Ablation for Small Periportal Hepatocellular Carcinoma: Comparison with Nonperiportal Hepatocellular Carcinoma.
    Lee SY; Hyun D; Cho SK; Shin SW; Jung SH; Chi SA
    Cardiovasc Intervent Radiol; 2018 Jan; 41(1):120-129. PubMed ID: 28924943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.